(Q40925827)

24 September 2017

1 reference

title

Recommendations of the first Michigan conference on prostate cancer (English)

1 reference

24 September 2017

Porter AT

1

1 reference

24 September 2017

Zimmerman J

2

1 reference

24 September 2017

Ruffin M

3

1 reference

24 September 2017

Chernew M

4

1 reference

24 September 2017

Callaghan C

5

1 reference

24 September 2017

Davis R

6

1 reference

24 September 2017

Lee F

7

1 reference

24 September 2017

Montie J

8

1 reference

24 September 2017

Swanson GM

9

1 reference

24 September 2017

Oesterling JE

10

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

24 September 2017

1 reference

24 September 2017

volume

48

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

519-33; discussion 533-4

1 reference

Prostate cancer: screening, diagnosis, and management

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Questioning the value of screening for prostate cancer in asymptomatic men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Ethics of a prostate cancer screening trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Statistical and epidemiologic data on urologic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Socioeconomic factors and cancer incidence among blacks and whites

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Prostate cancer. An overview of an increasing dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Clinical evidence for and implications of the multistep development of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Patterns of progression in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Watchful waiting for early stage prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Dietary fat, fatty acids and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Characteristics of men reporting for prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Cryosurgery in prostatic cancer: survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Prostate cancer: US-guided percutaneous cryoablation. Work in progress

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Control of prostate cancer with radiotherapy: long-term results.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Early Prostate Cancer: The National Results of Radiation Treatment from the Patterns of Care and Radiation Therapy Oncology Group Studies With Prospects for Improvement with Conformal Radiation and Adjuvant Androgen Deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Comparison of a conformal nonaxial boost with a four-field boost technique in the treatment of adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

The role of radical prostatectomy in the management of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer. A fifteen-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

Screening for prostate cancer. A decision analytic view

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900241-5

7 January 2021

10.1016/S0090-4295(96)00241-5

Identifiers

DOI

1 reference

24 September 2017

1 reference